Arvanil

• CAT Number: I002797
• CAS Number: 128007-31-8
• Molecular Formula: C28H41NO3
• Molecular Weight: 439.61
• Purity: ≥95%
• Synonyms: Arvanil; RT-011322; B-6699; I14-44667; RT011322; B6699; I1444667; RT 011322; B 6699; I14 44667;(5Z,8Z,11Z,14Z)-N-(4-hydroxy-3-methoxybenzyl)icosa-5,8,11,14-tetraenamide
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO
• Storage: Desiccate at -20C
• IUPAC Name: (5Z,8Z,11Z,14Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]icosa-5,8,11,14-tetraenamide
• InChI: InChI=1S/C28H41NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-28(31)29-24-25-21-22-26(30)27(23-25)32-2/h7-8,10-11,13-14,16-17,21-23,30H,3-6,9,12,15,18-20,24H2,1-2H3,(H,29,31)/b8-7-,11-10-,14-13-,17-16-
• InChIKey: QVLMCRFQGHWOPM-ZKWNWVNESA-N
• SMILES: CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCc1ccc(O)c(OC)c1

Arvanil(CAT: I002797) is a synthetic hybrid molecule that combines properties of anandamide and vanilloid receptor ligands, acting as a potent agonist for TRPV1 (transient receptor potential vanilloid type 1) and cannabinoid CB1 receptors. It is widely utilized in research on pain modulation, neuroinflammation, and appetite regulation. Arvanil’s dual activity enables studies into the interplay between the endocannabinoid and vanilloid systems, providing insights into their roles in neuropathic pain and other neurological conditions. Its high purity and consistency ensure reliable experimental outcomes, making Arvanil a valuable tool for advancing research in neurobiology, pharmacology, and therapeutic development.